Our experienced medical device professionals are committed to delivering sensors for the continuous monitoring of blood gasses allowing medical teams to make fast, accurate, life saving decisions based on knowledge gained in real time.
Elucido, latin for to light or to enlighten is the perfect word to describe how and what our evolutionary technology does for our Customers. Our technology uses light to evaluate and provide real time, highly accurate blood parameter measurements allowing our Customer to provide better patient outcomes and reduce hospital costs.
With years of experience, our medical team will engage with you to customize the Elucido® platform to integrate with the your systems and deliver customized products to you in the regulatory process.
The worldwide market for blood gas monitoring systems will reach $4.9 billion in 2023 with a 6.1% compound annual growth rate, driven by the increasing prevalence of chronic diseases, the aging population and the pressure on manufacturers to launch smart devices. Our Elucido® system, protected by a strong patent estate, is a technologically evolutionary, real time monitoring platform for integration into ex-vivo, in-vivo, and interstitial application